News Daily News Lp(a) Appears Tied to Myocardial Fibrosis: Observational Data Yael L. Maxwell December 13, 2023
Presentation AHA 2023 The Artesia trial: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation Presenter: Jeff Healey November 16, 2023
News Daily News Half of American Indian and Alaska Native Seniors Have CVD: Medicare Analysis L.A. McKeown September 25, 2023
News Daily News ‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF L.A. McKeown September 18, 2023
News Conference News ESC 2023 New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground Caitlin E. Cox August 30, 2023
News Daily News Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE Michael O'Riordan July 25, 2023
News Daily News CVD Risk Reduction With Exercise Also Seen in ‘Weekend Warriors’ Michael O'Riordan July 24, 2023
News Daily News Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism Caitlin E. Cox June 16, 2023
News Daily News Patients Most Vulnerable to CVD the Least Likely Use Wearable Devices Caitlin E. Cox June 13, 2023
News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023
News Daily News New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF L.A. McKeown April 19, 2023
News Daily News Inactivity Pandemic Poised to Undo CVD Prevention Advances Michael O'Riordan April 11, 2023
News Daily News More AF Surveillance Needed in Chemotherapy Trials, Meta-analysis Hints L.A. McKeown April 06, 2023
News Daily News Cardiac Biomarkers May Help Refine HF Risk Stratification, Progression L.A. McKeown February 17, 2023